Kara Murphy
파트너,
Kara
Kara Murphy is a Senior Partner and co-leader of our Global Healthcare Private Equity team.
Kara has over 20 years of healthcare and investing experience. She advises leading private equity investors and alternative asset managers across the full investment cycle. She has supported hundreds of due diligence assignments across the healthcare value chain. She has worked extensively with PE-backed portfolio companies on their value creation plans. Kara also supports investors on firm ambition, asset class strategy, fund operations, and fundraising.
Kara earned her MBA from Harvard Business School in 2001. She is also a graduate of Tufts University.
Kara Murphy discusses how private equity and corporate investors can evaluate business opportunities and risks that these trends create.
Recent Insights
- “Takeaways from Bain’s 2024 Healthcare Private Equity Report,” Webinar, 2024년1월23일
- “Healthcare Private Equity Market 2023: Year in Review and Outlook,” Global Healthcare Private Equity Report, 2024년1월3일, Report
- “Generative AI Will Transform Healthcare,” Global Healthcare Private Equity Report, 2024년1월3일, Report
- “Healthcare IT Hits a Speed Bump,” Global Healthcare Private Equity Report, 2024년1월3일, Report
- “Life Sciences: Navigating Shifts in the Innovation, Regulatory, and Operational Terrains,” Global Healthcare Private Equity Report, 2024년1월3일, Report
In the News
- “Healthcare private equity deals scored second-biggest year, finds new report from Bain & Company,” PE Hub, 2023년4월10일, 사모펀드
- “HCIT M&A in the wake of COVID-19; Blackstone goes shopping,” PE Hub, 2020년3월12일, 헬스케어
- “Column: Bain's Kara Murphy on the Amazon Effect, provider deal flow ,” Buyouts, 2018년4월18일, 헬스케어
- “Early Move Into Behavioral Health Leads to 12-Times Return for Waud,” WSJ Pro, 2018년3월27일, 사모펀드
- “Back to School: Bar rises for healthcare investors,” Buyouts, 2017년5월1일, 헬스케어